Mucosal-associated constant T (MAIT) cells expressing chimeric antigen receptors

摘要

The present invention relates generally to immunotherapy, in particular to immunotherapy for the treatment of cancer, infectious disease or autoimmune disease. More particularly, the present invention relates to mucosal-associated constant T (MAIT) cells expressing a chimeric antigen receptor (CAR), wherein the MAIT cells are allogeneic with respect to the subject to be treated.